GF Fund Management’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
Other funds holding ALNY
GF Fund Management's ALNY Position: Q3 2026 in Review
GF Fund Management increased its Alnylam Pharmaceuticals (ALNY) stake by 2.4% in Q3 2026, buying an estimated $180K and bringing the position to 30,479 shares worth $7.52M. The position accounts for 0.1% of the portfolio, ranked #111.
GF Fund Management first reported a position in ALNY in Q4 2024 and has held it in 8 quarters since. The position peaked at $12.1M in Q4 2025. 730 funds tracked by Wall St. Rank hold ALNY as of Q3 2026.
- GF Fund Management held 30,479 shares of Alnylam Pharmaceuticals worth $7.52M as of Q3 2026.
- GF Fund Management bought 709 Alnylam Pharmaceuticals shares in Q3 2026, an estimated $180K.
- Alnylam Pharmaceuticals made up 0.1% of GF Fund Management's portfolio in Q3 2026, its #111 holding.
- GF Fund Management first reported a position in Alnylam Pharmaceuticals in Q4 2024 and has held it in 8 quarters since.
- GF Fund Management's Alnylam Pharmaceuticals position peaked at $12.1M in Q4 2025.
- 730 funds tracked by Wall St. Rank held Alnylam Pharmaceuticals as of Q3 2026.
Based on GF Fund Management's 13F filing for Q3 2026, filed 26 Oct 2026.